Breakthrough Invasive Candidiasis in Patients on Micafungin
- Autores
- Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; Alexander, Barbara D.
- Año de publicación
- 2010
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study.
Fil: Pfeiffer, Christopher D.. University of Duke; Estados Unidos
Fil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. State University of New Jersey; Estados Unidos
Fil: Zaas, Aimee K.. University of Duke; Estados Unidos
Fil: Perfect, John R.. University of Duke; Estados Unidos
Fil: Perlin, David S.. State University of New Jersey; Estados Unidos
Fil: Alexander, Barbara D.. University of Duke; Estados Unidos - Materia
-
Echinocandinas
Resistencia
Candida
micafungina - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/100414
Ver los metadatos del registro completo
| id |
CONICETDig_e4c9d3fb958b111163676d0c831eb638 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/100414 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Breakthrough Invasive Candidiasis in Patients on MicafunginPfeiffer, Christopher D.Garcia, Guillermo ManuelZaas, Aimee K.Perfect, John R.Perlin, David S.Alexander, Barbara D.EchinocandinasResistenciaCandidamicafunginahttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study.Fil: Pfeiffer, Christopher D.. University of Duke; Estados UnidosFil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. State University of New Jersey; Estados UnidosFil: Zaas, Aimee K.. University of Duke; Estados UnidosFil: Perfect, John R.. University of Duke; Estados UnidosFil: Perlin, David S.. State University of New Jersey; Estados UnidosFil: Alexander, Barbara D.. University of Duke; Estados UnidosAmerican Society for Microbiology2010-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/100414Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; et al.; Breakthrough Invasive Candidiasis in Patients on Micafungin; American Society for Microbiology; Journal of Clinical Microbiology; 48; 7; 7-2010; 2373-23800095-1137CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1128/JCM.02390-09info:eu-repo/semantics/altIdentifier/url/https://jcm.asm.org/content/48/7/2373.longinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897493/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:04:56Zoai:ri.conicet.gov.ar:11336/100414instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:04:56.786CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| title |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| spellingShingle |
Breakthrough Invasive Candidiasis in Patients on Micafungin Pfeiffer, Christopher D. Echinocandinas Resistencia Candida micafungina |
| title_short |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| title_full |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| title_fullStr |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| title_full_unstemmed |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| title_sort |
Breakthrough Invasive Candidiasis in Patients on Micafungin |
| dc.creator.none.fl_str_mv |
Pfeiffer, Christopher D. Garcia, Guillermo Manuel Zaas, Aimee K. Perfect, John R. Perlin, David S. Alexander, Barbara D. |
| author |
Pfeiffer, Christopher D. |
| author_facet |
Pfeiffer, Christopher D. Garcia, Guillermo Manuel Zaas, Aimee K. Perfect, John R. Perlin, David S. Alexander, Barbara D. |
| author_role |
author |
| author2 |
Garcia, Guillermo Manuel Zaas, Aimee K. Perfect, John R. Perlin, David S. Alexander, Barbara D. |
| author2_role |
author author author author author |
| dc.subject.none.fl_str_mv |
Echinocandinas Resistencia Candida micafungina |
| topic |
Echinocandinas Resistencia Candida micafungina |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study. Fil: Pfeiffer, Christopher D.. University of Duke; Estados Unidos Fil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. State University of New Jersey; Estados Unidos Fil: Zaas, Aimee K.. University of Duke; Estados Unidos Fil: Perfect, John R.. University of Duke; Estados Unidos Fil: Perlin, David S.. State University of New Jersey; Estados Unidos Fil: Alexander, Barbara D.. University of Duke; Estados Unidos |
| description |
For Candida species, a bimodal wild-type MIC distribution for echinocandins exists, but resistance to echinocandins is rare. We characterized isolates from patients with invasive candidiasis (IC) breaking through ≥3 doses of micafungin therapy during the first 28 months of its use at our center: MICs were determined and hot-spot regions within FKS genes were sequenced. Eleven of 12 breakthrough IC cases identified were in transplant recipients. The median duration of micafungin exposure prior to breakthrough was 33 days (range, 5 to 165). Seventeen breakthrough isolates were recovered: FKS hot-spot mutations were found in 5 C. glabrata and 2 C. tropicalis isolates; of these, 5 (including all C. glabrata isolates) had micafungin MICs of >2 μg/ml, but all demonstrated caspofungin MICs of >2 μg/ml. Five C. parapsilosis isolates had wild-type FKS sequences and caspofungin MICs of 0.5 to 1 μg/ml, but 4/5 had micafungin MICs of >2 μg/ml. The remaining isolates retained echinocandin MICs of ≤2 μg/ml and wild-type FKS gene sequences. Breakthrough IC on micafungin treatment occurred predominantly in severely immunosuppressed patients with heavy prior micafungin exposure. The majority of cases were due to C. glabrata with an FKS mutation or wild-type C. parapsilosis with elevated micafungin MICs. MIC testing with caspofungin identified all mutant strains. Whether the naturally occurring polymorphism within the C. parapsilosis FKS1 gene responsible for the bimodal wild-type MIC distribution is also responsible for micafungin MICs of >2 μg/ml and clinical breakthrough or an alternative mechanism contributes to the nonsusceptible echinocandin MICs in C. parapsilosis requires further study. |
| publishDate |
2010 |
| dc.date.none.fl_str_mv |
2010-07 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/100414 Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; et al.; Breakthrough Invasive Candidiasis in Patients on Micafungin; American Society for Microbiology; Journal of Clinical Microbiology; 48; 7; 7-2010; 2373-2380 0095-1137 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/100414 |
| identifier_str_mv |
Pfeiffer, Christopher D.; Garcia, Guillermo Manuel; Zaas, Aimee K.; Perfect, John R.; Perlin, David S.; et al.; Breakthrough Invasive Candidiasis in Patients on Micafungin; American Society for Microbiology; Journal of Clinical Microbiology; 48; 7; 7-2010; 2373-2380 0095-1137 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1128/JCM.02390-09 info:eu-repo/semantics/altIdentifier/url/https://jcm.asm.org/content/48/7/2373.long info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897493/ |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
American Society for Microbiology |
| publisher.none.fl_str_mv |
American Society for Microbiology |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1846782400687767552 |
| score |
12.982451 |